Moderna Shares Tumble After Cutting Sales Forecast For COVID Vaccine
(Reuters) – Moderna Inc on Thursday cut the annual sales forecast for its COVID-19 vaccine citing short-term supply constraints that would push some vaccine deliveries out to next year, sending its shares down 15% before the bell. The vaccine maker reported sales of $3.36 billion in the third quarter, missing Wall Street estimates of $3.53…
